These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9106733)

  • 21. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
    Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic neuroleptic treatment does not suppress the dynamic characteristics of the dopaminergic receptor D2 system.
    Andia I; Zumarraga M; Retuerto F; Zamalloa I; Davila R
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):181-91. PubMed ID: 7906895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain.
    Booth RG; Baldessarini RJ; Marsh E; Owens CE
    Brain Res; 1994 Oct; 662(1-2):283-8. PubMed ID: 7859086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
    Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
    Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain.
    Shapiro LA; Offord SJ; Ordway GA
    Brain Res; 1995 Apr; 677(2):250-6. PubMed ID: 7552250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesolimbic 7-OH-DPAT affects locomotor activities in rats.
    Meyer ME
    Pharmacol Biochem Behav; 1996 Oct; 55(2):209-14. PubMed ID: 8951956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desenkephalin-gamma-endorphin and neuroleptics counteract the DP-7-ATN-induced hypomotility after intra-accumbens treatment.
    Radhakishun FS; Horn AS; Van Ree JM
    Eur J Pharmacol; 1988 Feb; 147(1):137-40. PubMed ID: 2897307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice.
    Suzuki T; Maeda J; Funada M; Misawa M
    Neurosci Lett; 1995 Feb; 187(1):45-8. PubMed ID: 7617299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
    Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors.
    Jaen JC; Caprathe BW; Pugsley TA; Wise LD; Akunne H
    J Med Chem; 1993 Nov; 36(24):3929-36. PubMed ID: 7902870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol and apomorphine differentially affect neuropeptidase activity.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1996 Apr; 277(1):113-20. PubMed ID: 8613907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ; Baker LE
    Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.
    Rodríguez De Fonseca F; Rubio P; Martín-Calderón JL; Caine SB; Koob GF; Navarro M
    Eur J Pharmacol; 1995 Feb; 274(1-3):47-55. PubMed ID: 7768280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats.
    Toua C; Brand L; Möller M; Emsley RA; Harvey BH
    Neuroscience; 2010 Jan; 165(2):492-9. PubMed ID: 19854242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.